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Abstract: Manual Vacuum Aspiration (MVA) is an action to evacuate the 
uterine cavity up to 14 weeks gestation. In a more extensive pregnancy, it is 
worried that the action of the MVA is less clean so that it will still repeat 
the action of sharp curettage.  This article reports a multigravida aged 42 
years old, G5P2A2, intrauterine fetal death (IUFD) at 18 weeks, 
undergoing MVA. Diagnosis of IUFD was performed using ultrasound 
examination. Before MVA was done, the patient was previously given 100 
μg of misoprostol orally for dilation. This pregnancy was the third 
pregnancy with a second husband, all of whom had abortions. Manual 
Vacuum Aspiration had a minimal risk of uterine injury. After MVA was 
conducted, ultrasound examination was repeated to confirm a clean uterine 
cavity. It had been carried out on an indication of IUFD of 18 weeks 
gestation with the result of a clean uterine cavity and minimal bleeding. 
Furthermore, Post-Abortion Intra-Uterine Device (PAIUD) was installed 
adequately, not causing complaints. Based on the result, it can be 
concluded that MVA is effective for evacuation of uterine cavities on 18 
weeks gestation. 
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Abstrak: Aspirasi vakum manual (AVM) merupakan tindakan untuk evakuasi 
kavum uteri hingga usia kehamilan 14 minggu. Oleh karena pada kehamilan yang 
lebih besar dikhawatirkan tindakan AVM kurang bersih, sehingga masih 
menimbulkan gejala sisa berupa perdarahan, yang mungkin harus diulang dengan 
tindakan kuretase tajam. Artikel ini menyampaikan case report seorang 
multigravida berusia 42 tahun, G5P2A2 hamil 18 minggu dengan intra uterine 
fetal death (IUFD), yang menjalani AVM untuk evakuasi kavum uteri. Diagnosis 
IUFD dengan menggunakan pemeriksaan Ultra Sono Grafi (USG). Sebelum 
tindakan AVM diberikan misoprostol 100 µg per oral untuk dilatasi. Kehamilan 
ini adalah kehamilan ketiga dengan suami kedua, yang semuanya abortus. AVM 
berisiko minimal terjadi perlukaan uterus. Setelah tindakan AVM, bersih tidaknya 
kavum uteri dievaluasi dengan menggunakan pemeriksaan USG. Sudah dilakukan 
AVM atas indikasi IUFD usia kehamilan 18 minggu dengan hasil kavum uteri 
bersih, perdarahan minimal, IUD paska abortus (IUDPA) yang dipasang terpasang 
dengan baik, tidak menimbulkan keluhan. Aspirasi Vakum Manual (AVM) efektif 
untuk tindakan evakuasi kavum uteri untuk usia kehamilan 18 minggu.  
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INTRODUCTION 
 
Manual Vacuum Aspiration (MVA) is an act of evacuation of the uterine cavity by vacuuming instead 
of being scraped off with a curettage spoon. This vacuuming action is expected not to damage the 
endometrial layer compared to evacuation using a curettage spoon. The expected long-term effect of 
vacuuming is no placental adhesions for the subsequent pregnancy. The use of MVA reduces the likelihood 
of symptomatic synechiae occurrences.1 Therefore, the risk of the placenta sticking to its insertion, called 
placenta accreta, is a medical indication that increases the risk of morbidity and mortality in pregnant women. 
Intrauterine Fetal Death (IUFD) is the condition of the death of the fetus in the womb because the 
fetal heart rate is no longer detected. Several factors causing fetal death, in this case, may be due to maternal 
age over 40 years.2 IUFD conditions require immediate evacuation of the uterine cavity. The amount of 
gestational age of 18 weeks is measured as high as 3 fingers below the center. The amount of gestational age 
requires proper uterine cavity evacuation. Evacuation of the uterine cavity using MVA is indicated for the 
evacuation of the uterine cavity until 14 weeks gestation3 or not more than 12 week’s gestation.4  
This paper is a case report about the evacuation of uterine cavities in IUFD cases at 18 weeks 
gestation using MVA preceded by administration of 100 μg misoprostol orally for dilation. This case is 
interesting as the respondents experienced 3x pregnancies, all of which experienced abortions. All three 
pregnancies were from a marriage with a second husband and had no children born healthy. AVM has a 
minimal risk of injuring the endometrium. AVM action was chosen to minimize endometrial injury as the 
respondent still expected to get pregnant with healthy fetal development. Meanwhile, AVM is usually done 
at a gestational age of no more than 12 or 14 weeks.4  
MVA was firstly described in the 1970s. MVA is an action used in the handling of incomplete abortion. 
This action is widely used in the United States of America (USA), Asia, Europe, and Africa.5 Many centers have 
not applied MVA to evacuate the uterine cavity yet. Therefore, the use of MVA in clinical practice has not 
mainly been reported.6 England is one of the countries that has not used MVA much to manage uterine cavity 
evacuation. Based on that reason, Speedie et al. felt the need to promote the use of MVA7. MVA is an 
alternative action for the evacuation of the uterine cavity in cases of an incomplete abortion.8  
Incomplete abortion is a miscarriage of the resultant conception that has not entirely come out of 
the uterine cavity but is still partly in the uterine cavity.8,9 If an abortion occurs, incompleteness can increase 
maternal morbidity.9 Studies comparing 400μg of sublingual misoprostol with MVA showed that misoprostol 
is analogous to MVA as the first line in managing incomplete abortion.9 The advantages of using MVA for the 
evacuation of uterine cavities are that MVA is safer, less painful, and more cost-effective than sharp 
curettage. More importantly, MVA has a lower risk of uterine perforation than sharp curettage. MVA 




The patient was a multigravida aged 42-year-old with 18 weeks gestation presented with IUFD. She 
was in the 3rd P0A2 pregnancy from her second husband. With the first husband, the patient already had two 
healthy growing children, P2A0. History of obstetrics with a second husband as G3P0A2 included the first and 
second pregnancy abortion in 2017 and 2018, performed curettage. The third pregnancy underwent an IUFD 
and performed MVA.  
The oral misoprostol 100 g was given previously for dilation, which then appeared to be profuse 
bleeding. The AVM was then performed in the operating room under anesthesia. After the AVM procedure 
was declared clean, the Post-Abortion Intra-Uterine Device (PAIUD) was installed to handle the evacuation 
of the uterine cavity and rest the uterus for at least the next six months. Complaints of bleeding had been 
felt three days before entering the hospital. When more blood came out, the patient went to a midwife 
before being referred to the hospital emergency Installation. Doctors after examining the patient, providing 
therapy: allylestrenol 2x1 and isoxsuprine 3x 1/2 tablet. The patient was discharged. Two days later, more and 
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Figure 1. Ultrasound results: a single fetus, spalding sign (+), FHR (-), diagnosed with IUFD  
 
When vaginal bleeding got worse, it was decided to do an MVA emergency action. The patient 
stopped eating and drinking. The patient's general condition was good, with a high fundus uterine of 3 central 
lower fingers. During the implementation of the MVA, they planned to conduct PAIUD. After the fetus has 
been removed with forceps, the bleeding before MVA was 200 ml. Meanwhile, the fetus & part of the 
placenta appeared. MVA was performed with a 12 cm sondage and anteflexed uterus (AF). It lasted for 10 
minutes and obtained as much as 50 ml of tissue residue and 50 ml of bleeding. After the MVA action was re-
condensed, uterine depth was 11 cm, and Cu-T type PAIUD was continued. PAIUD was the most preferred 
type of contraception (58.6%) after MVA compared to other types, namely: pills (16.4%), implants (13.5%), 
injections (7.9%), and condoms (1, 3%).10 The installation of a PAIUD was intended to rest the uterus post-
abortion for at least six months. Meanwhile, the tracking phase can be done, within 6 months, to cause 
abortion and its treatment. The patient would also be psychologically calmer to prepare for the subsequent 
pregnancy. The contraception was chosen as an IUFD because it was non-hormonal, so it did not interfere 
with menstruation. The patient's fertility returned immediately after the release of the IUFD. Besides, the 
IUFD was long-term contraception. Thus, if within 6 months the patient was not ready to get pregnant again, 




The patient's general condition was still anesthetized, with vital signs: blood pressure 100/70 mmHg, 
pulse 80x/minute, respiratory 20x/minute, with afebrile temperature. The patient was monitored in the 
recovery room for three hours. During monitoring in the recovery room, the patient's general condition was 
good, with good vital signs and no complaints of bleeding. The patient was later moved to the wardroom. At 
the next day's visit, the general condition of the patient was good. She was allowed to go home. One week 
later, the patient's general condition was normal, with vital signs of blood pressure 120/80 mmHg, smooth 
defecation (bowel movements) and urination, no bleeding, no complaints of pain, and no complaints against 
PAIUDs that were mounted. Ultrasound results showed a clean uterus with visible PAIUD in situ. 
 
 
Figure 2. Results of the 7th-day MVA ultrasound with PAIUD in situ 
 
The patient came in control, waiting for menstruation. She got her menstruation about two months 
after MVA. Her menstruation lasted for 4 days, with a normal amount of blood. There were no complaints 
about the IUFD, no pain during menstruation, and no pain during sexual intercourse. 
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DISCUSSION  
 
Manual Vacuum Aspiration is the standard measure for evacuation of the uterine cavity in cases of 
miscarriage in the first trimester.5 In this case report, evacuation of the uterine cavity with MVA is carried out 
at 18 week-gestation. The uterine cavity was much larger than the 12-14 week gestational age, so there was a 
concern that unclean tissue would occur. The implementation of MVA was carried out in the operating room 
with Total Intravenous Anesthesia (TIVA) so that the respondent was calm since previously, she had 
panicked, experienced bleeding, and repeated abortions. In addition, as the respondent's age was more than 
40 years old, the use of TIVA was under the supervision of an anesthesiologist. TIVA is an anesthetic that is 
commonly used in cases of uterine cavity evacuation. The parenteral opioid used was pethidine 50 mg. 
Sedation such as intravenous midazolam was also used when it was needed.4 
In this case, the bleeding and tissue discharge occurred, with the administration of 100 µg 
misoprostol first. Thus, the diagnosis turned into incomplete abortion. The evacuation of the uterine cavity 
as an incomplete abortion was performed with MVA. The use of a dose of 100 g misoprostol orally was chosen 
because the respondent experienced bleeding. Larger doses of misoprostol (400 g) were chosen either orally 
or vaginally if cervical ripening was required.11 
Misoprostol used for the evacuation of the uterine cavity required additional use of MVA in 17% of 
subjects12. The dose of misoprostol in this case report differed from a study comparing the use of misoprostol 
against MVA as a treatment for evacuation of the uterine cavity. The amount of misoprostol used was 600 
µg at gestational age less than 13 weeks.13,14 
The results were obtained when the control patient experienced a clean uterus with visible PAIUD 
in situ one week later. Begum et al., reported that MVA was recommended in Bangladesh for the 
management of incomplete abortion. It is because the MVA procedure is safe, effective, faster, cheaper, 
minimal pain, shorter hospital stay, and less risk of uterine perforation. Thus, the use of MVA in incomplete 
abortion reduced maternal morbidity and mortality.8 In line with the research of Odland et al., MVA has begun 
to be practiced in several hospitals in Malawi and has even become the leading management of incomplete 
abortion cases due to the minimal complications it caused.15 
In this case, the MVA procedure was safe, effective, and faster, only requiring 10 minutes in the 
process, even though the uterine cavity was quite large due to 18 weeks gestation. At the time of evaluation, 
the uterine cavity was clear, and PAIUD was applied. Further, Blandine et al., reported that MVA is effective 
in managing complications in early pregnancy.9 It serves minimal complications of the incidence of uterine 
perforation, bleeding, and the remaining tissue after the MVA action. MVA is a safe, easy-to-do, and cost-
effective procedure that benefits both patients and health facilities.4,6,9 In this case report, the magnitude of 
18 weeks gestation did not become an obstacle to cleaning the uterine cavity using the MVA procedure. 
MVA's action is a procedure that is more effective than sharp curettage, which Brown et al., MVA also 
conveyed to be cheaper with shorter hospital stays.16 More importantly, MVA results in a smaller amount of 
bleeding, fewer serious complications, aside from being quick and easy to work on, and minimal pain 
compared to sharp curettage.16 
MVA can be done more quickly. More minimal pain and a smaller amount of bleeding are also 
obtained from the statement of Odland et al., MVA procedure is an evacuation of the uterine cavity in cases 
of incomplete abortion, up to 14 weeks gestation, and sufficient use of local anesthesia or analgesia.15 In 
addition, MVA can be done in outpatient polyclinics and places with minimal human and equipment resources 
as it does not require sedation and electrical devices.3,17 It is even possible that MVA can be done by trained 
midwives and nurses.18,19 The WHO recommends that AVM is a safer procedure than dilation and curettage 
for termination of pregnancy.20 The safety of MVA procedures is also conveyed in several scientific 
publications that have been submitted. In addition, vacuum aspiration manually or electrically is as good as 




Manual Vacuum Aspiration as a procedure for evacuation of the uterine cavity in IUFD at 18 weeks 
gestation, gave good, safe, effective, clean, and fast results in the process of evacuation. The MVA procedure 
could be recommended as an evacuation of uterine cavities in cases of miscarriage with a gestational age of 




| 148  
CONFLICT OF INTEREST 
 




1. Padrón L. Manual Compared with Electric Vacuum Aspiration for Treatment of Molar Pregnancy. Obstet. 
Gynecol. 2018;131(4): 652–659. https://doi.org/10.1097/AOG.0000000000002522 
2. Soewarto S. Kematian Janin. PT Bina Pustaka, 2016. 
3. Odland ML. Decrease in Use of Manual Vacuum Aspiration in Postabortion Care in Malawi: A cross-Sectional 
Study from Three Public Hospitals. PLoS One 9; 2014: 2008–2012.  
https://doi.org/10.1371/journal.pone.0100728 
4. Azman A, Sakri NAM, Mohd Kusni NA, Mansor NH & Zakaria ZA. Manual vacuum aspiration: a safe and 
effective surgical management of early pregnancy loss. Int. J. Reprod. Contraception, Obstet. Gynecol. 8, 2256 
(2019). https://doi.org/10.18203/2320-1770.ijrcog20192413 
5. Anozie OB,  Nwafor JI, Ukaegbe CI, Esike CU, Anozie RO, Lawani LO, et al. A 5-Year Retrospective Study on 
the Use of Manual Vacuum Aspiration in the Federal Teaching Hospital Abakaliki. Open J. Obstet Gynecol; 
2019; 9(2): 142–148. https://doi.org/10.4236/ojog.2019.92015 
6. Zommere I, Umaru A & Mulbagal K. Should Manual Vacuum Aspiration for Miscarriage be the Preferred 
Option Over a Surgical Evacuation? Eur J. Obstet Gynecol Reprod Biol. 2016: 206. 
7. Speedie J & Robson S. The Evolution of a One-stop’ Out Patient Manual Vacuum Aspiration Service for 
Termination of Pregnancy. BMJ Sex Reprod Heal. 2018; 44: 58–60. https://doi.org/10.1136/bmjsrh-2017-
101806 
8. Begum S, Rashid M & Jahan A. Clinical Study on Management of Incomplete Abortion by Manual Vacuum 
Aspiration (MVA). J Enam Med Coll. 2012; 2(1): 24–28. https://doi.org/10.3329/jemc.v2i1.11918 
9. Blandine T. Oral Misoprostol as First-line Care for Incomplete Abortion in Burkina Faso. Int J Gynecol Obstet. 
2012; 119(2): 166–169. https://doi.org/10.1016/j.ijgo.2012.05.036 
10. Pillai M. Introduction of a Manual Vacuum Aspiration Service: A model of Service within a NHS Sexual Health 
Service. J Fam Plan Reproduction Health Care. 2015; 41: 27–32. https://doi.org/10.1136/jfprhc-2013-100700 
11. Revankar VM. Tablet Misoprostol as a Cervical Priming Agent Prior to Surgical Abortion. Int J Reproduction 
Contraception Obstet Gynecol. 2017; 6(7): 3004. http://dx.doi.org/10.18203/2320-1770.ijrcog20172924 
12. Ibiyemi KF & Adesina KT. ىوتسلما في اييرجين ةبرتج ةيئاوشع مادختسال ءاود لوتسوربوزيلما مفالب ةنراقم ءارجإب طفشال يئاولخا  
2019 :43–38 ,19 .يوديال جالعل ضاهجإلا  يرغ لمتكلما في ىفشتسم يثالث . 
13. Nwafor JI. Misoprostol Versus MVA for Treatment. Niger. JCP. 2020: 638–646. 
https://doi.org/10.4103/njcp.njcp_379_19 
14. Ahmed SK, Ashraf R & Khaloon LE. Comparison of Sublingual Misoprostol and Manual Vacuum Aspiration 
for the Treatment of Incomplete Abortion in First Trimester in Terms of Frequency of Decreased Haemoglobin 
Levels. JRMC. 2017; 21(3): 208–210. 
15. Odland ML. The Use of Manual Vacuum Aspiration in the Treatment of Incomplete Abortions: A Descriptive 
Study from Three Public Hospitals in Malawi. Int J Environ Res Public Health. 2018; 15(2): 370. 
https://doi.org/10.3390/ijerph15020370 
16. Brown HC. Management of Incomplete Abortion in South African. BJOG An Int J Obstet Gynaecol. 2003; 
110(4): 371–377. https://doi.org/10.1046/j.1471-0528.2003.t01-1-02036.x 
17. Sharma M. Manual Vacuum Aspiration: An Out Patient Alternative for Surgical Management of Miscarriage. 
Obstet Gynaecol. 2015; 17(3): 157–161. https://doi.org/10.1111/tog.12198 
18. Bourret KM. Midwives’ Integration of Post Abortion Manual Vacuum Aspiration in the Democratic Republic 
of Congo: A Mixed Methods Case Study & Positive Deviance Assessment. BMC Health Serv Res. 2020; 20: 1–
16. https://doi.org/10.1186/s12913-020-05997-7 
19. Sheldon S & Fletcher J. Vacuum Aspiration for Induced Abortion Could be Safely and Legally Performed by 
Nurses and Midwives. J Fam Plan Reprod Heal Care. 2017; 43(4): 260–264. https://doi.org/10.1136/jfprhc-
2016-101542 
20. Pawde AA, Ambadkar A & Chauhan AR. A Study of Incomplete Abortion Following Medical Method of 
Abortion (MMA). J Obstet Gynecol India. 2016; 66(4): 239–243. https://doi.org/10.1007/s13224-015-0673-1 
21. Dean G. Manual Compared with Electric Vacuum Aspiration for Abortion at Less than 6 Weeks of Gestation. 
Obstet Gynecol. 2015; 125(5): 1121–1129. https://doi.org/10.1097/AOG.0000000000000787 
 
 
